Clinical Trials Sponsored by British Columbia Cancer Agency

Total 255 results

British Columbia Cancer Agency

Recruiting

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

Prostate Cancer Metastatic | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate Cancer

Canada
British Columbia Cancer Agency

Recruiting

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

Pathologic Processes | Neoplasms | Neoplasm Metastasis | Neoplastic Processes

Canada
British Columbia Cancer Agency

Recruiting

DOTATOC PET/CT for Imaging NET Patients

Pituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary Carcinoma

Canada
British Columbia Cancer Agency

Recruiting

Partial Prostate Salvage High Dose Rate Brachytherapy (SalvageHDR)

Recurrent Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer (TAPER)

Endometrial Cancer

Canada
British Columbia Cancer Agency

Active, not recruiting

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Prostate Cancer

Canada
British Columbia Cancer Agency

Approved for marketing

18F-FDG PET Imaging in Cardiac Sarcoidosis

Cardiac Sarcoidosis

Canada
British Columbia Cancer Agency

Active, not recruiting

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

Neoplasms | Urogenital Neoplasms | Disease Attributes | Prostate Cancer | Prostatic Neoplasm | Prostatic Disease

Canada
British Columbia Cancer Agency

Completed

Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases (Amadeus)

Brain Metastases

Canada
British Columbia Cancer Agency

Completed

US-CT Fusion for Post Implant Dosimetry

Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer

Head and Neck Cancer | Radiotherapy Induced Mucositis

Canada
British Columbia Cancer Agency

Terminated

Intraprostatic MAXimal Simultaneous Boost

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

C-arm Cone-beam CT in Prostate Brachytherapy (C-arm)

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy (FTPC)

Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

Feasibility of VMAT and CBCT for Head and Neck Carcinomas

Head and Neck Carcinoma

Canada
British Columbia Cancer Agency

Completed

Can 3D Ultrasound Be Used Reproducibly by Radiation Therapists in Partial Breast Image-Guided Radiation Therapy (IGRT)

Radiation Therapy for Primary Breast Cancer

Canada
British Columbia Cancer Agency

Completed

Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy

Hormone Refractory Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

Acupuncture in Palliative Cancer Care

Neoplasms | Palliative Care

Canada
British Columbia Cancer Agency

Completed

A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer

Adenocarcinoma of the Prostate

Canada
British Columbia Cancer Agency

Not yet recruiting

PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer (PATH)

Head and Neck Cancer
British Columbia Cancer Agency

Recruiting

PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc (PREDiCTc)

Cancer

Canada
British Columbia Cancer Agency

Recruiting

[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer

Prostatic Cancer | Prostatic Neoplasm

Canada
British Columbia Cancer Agency

Recruiting

PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA (PROTRACT)

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Canada
British Columbia Cancer Agency

Recruiting

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

Canada
British Columbia Cancer Agency

Withdrawn

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

Neuroendocrine Tumors | Carcinoid Tumor | Gastrinoma | Insulinoma | Vipoma | Gastroenteropancreatic Neuroendocrine Tumor | Pulmonary Carcinoid Tumor

Canada
British Columbia Cancer Agency

Withdrawn

FDGal PET/CT to Detect Hepatocellular Carcinoma

Liver Cirrhosis | Hepatocellular Carcinoma | Chronic Liver Disease

Canada
British Columbia Cancer Agency

No longer available

18F-FDOPA PET in Neuroendocrine Tumours

Thyroid Cancer, Medullary | Neuroblastoma | Pheochromocytoma | Carcinoid Tumor | Paraganglioma | Insulinoma

Canada
British Columbia Cancer Agency

Active, not recruiting

Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases

Metastatic Tumors

Canada
British Columbia Cancer Agency

Completed

High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule (Dosepainting)

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath (Covid-VOC)

Covid19

Canada
British Columbia Cancer Agency

Completed

18F-AmBF3-TATE PET/CT for Imaging NET Patients

Neuroendocrine Tumors

Canada
British Columbia Cancer Agency

Completed

18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology

Melanoma | Lymphoma | Lung Neoplasms | Colorectal Neoplasms | Brain Neoplasms

Canada
British Columbia Cancer Agency

Unknown

Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy

Arthralgia | Myalgia | Invasive Breast Cancer | Chemotherapeutic Toxicity
British Columbia Cancer Agency

Unknown

Feasibility Study of MRI Imaging on Parotid Gland Stimulation (SPIT)

Parotid Neoplasms

Canada
British Columbia Cancer Agency

Withdrawn

Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Canada
British Columbia Cancer Agency

Unknown

Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis

Rectal Bleeding

Canada
British Columbia Cancer Agency

Unknown

Randomized Anastrozole Exercise Trial (RAE)

Musculoskeletal Symptoms

Canada
British Columbia Cancer Agency

Completed

Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy (Anterior EPI) (Anterior EPI)

Breast Cancer

Canada
British Columbia Cancer Agency

Completed

Bone Health in Gynecologic Cancers-does FOSAVANCE Help? (FOSAVANCE)

Ovarian Cancer

Canada
British Columbia Cancer Agency

Completed

Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial

Advanced Colorectal Cancer

Canada
British Columbia Cancer Agency

Recruiting

Evidence Development in Cancer Treatment - Real World: PREDiCTrw

Cancer

Canada
British Columbia Cancer Agency

Not yet recruiting

Diagnostic CT Palliative Radiotherapy: Feasibility Study of Treating Bone Metastases Without a CT Simulation (dCT-PRT)

Bone Metastases
British Columbia Cancer Agency

Not yet recruiting

Preliminary Assessment of [18F]BL40 in PET/CT Scans

Multiple Myeloma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma

Canada
British Columbia Cancer Agency

Not yet recruiting

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

B-cell Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell Leukemia | B-cell Acute Lymphoblastic Leukemia | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | High-grade B-cell Lymphoma

Canada
British Columbia Cancer Agency

Recruiting

CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease

Non Small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal Metastasis

Canada
British Columbia Cancer Agency

Recruiting

A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer

Ovarian Cancer | Platinum-resistant Ovarian Cancer

Canada
British Columbia Cancer Agency

Recruiting

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) (PROMPT)

Oligometastatic Prostate Cancer

Canada
British Columbia Cancer Agency

Not yet recruiting

Dynamic Whole Body PET/ MRI

Prostatic Cancer

Canada
British Columbia Cancer Agency

Recruiting

Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Prostatic Neoplasms | Prostate Cancer | Neuroendocrine Tumors | Neuroblastoma | Carcinoid Tumor | Paraganglioma

Canada
British Columbia Cancer Agency

Recruiting

Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease (OPTiMAL)

Prostate Cancer

Canada

Clinical Trials Sponsored by British Columbia Cancer Agency

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations